MSFT 410.37 -0.8486% AAPL 222.91 0.4144% NVDA 135.3699 0.0% GOOGL 171.29 -0.0233% GOOG 172.65 -0.3003% AMZN 197.93 -0.6119% META 567.16 -0.5297% AVGO 168.92 -0.9732% TSLA 248.98 -0.4319% TSM 192.98 -1.9261% LLY 818.79 -0.5333% V 290.73 -0.4588% JPM 222.93 -0.8539% UNH 567.53 -0.0308% NVO 111.97 -0.1684% WMT 82.19 0.4768% LVMUY 131.75 -0.6335% XOM 114.95 -1.6849% LVMHF 660.0 -0.6323% MA 508.28 -0.2316%

Cyclacel Pharmaceuticals Inc

Healthcare US CYCC

0.6269USD
0.0071(1.15%)

Last update at 2024-11-01T20:00:00Z

Day Range

0.600.64
LowHigh

52 Week Range

1.3013.20
LowHigh

Fundamentals

  • Previous Close 0.62
  • Market Cap2.94M
  • Volume213054
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-22.46400M
  • Revenue TTM0.45M
  • Revenue Per Share TTM0.47
  • Gross Profit TTM -0.45500M
  • Diluted EPS TTM-21.59

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -25.91500M -22.73400M -9.68100M -9.12500M -8.62500M
Minority interest - - - - -
Net income -21.19800M -18.88700M -8.44500M -7.82800M -7.28800M
Selling general administrative 7.38M 7.46M 5.88M 5.02M 5.37M
Selling and marketing expenses - - - - -
Gross profit - - 0.00588M -4.65800M 0.15M
Reconciled depreciation 0.03M 0.04M 0.02M 0.02M 0.03M
Ebit -27.65600M -22.93800M -10.63600M -9.68100M -9.48700M
Ebitda -27.88900M -22.98200M -10.65800M -9.78200M -9.45800M
Depreciation and amortization -0.23300M -0.04400M -0.02200M -0.10100M 0.03M
Non operating income net other - - -2.82000M 0.56M 0.92M
Operating income -27.65600M -22.93800M -10.63600M -9.68100M -9.54800M
Other operating expenses 27.66M 22.94M 10.64M 9.68M 9.70M
Interest expense -2.00600M 0.29M 1.00M 0.68M 0.00000M
Tax provision -4.71700M -3.84700M -1.23600M -1.29600M -1.33700M
Interest income 0.21M 0.02M 0.04M 0.22M 0.33M
Net interest income 0.21M 0.02M 0.04M 0.22M 0.33M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -4.71700M -3.84700M -1.23600M -1.29700M -1.33700M
Total revenue 0.00000M 0.00000M 0.00588M 0.00000M 0.15M
Total operating expenses 27.66M 22.94M 10.64M 9.68M 9.70M
Cost of revenue - - - 4.66M 4.33M
Total other income expense net 1.74M 0.20M 0.95M 0.56M 0.59M
Discontinued operations - - - - -
Net income from continuing ops -21.19800M -18.88700M -8.44500M -7.83000M -7.28800M
Net income applicable to common shares -21.39900M -19.08800M -8.64600M -8.03100M -7.48900M
Preferred stock and other adjustments - - 0.20M 0.20M 0.20M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 8.80M 27.50M 42.59M 36.80M 15.31M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 1.13M 6.07M 0.08M 0.07M 0.10M
Total liab 8.20M 11.99M 5.32M 3.54M 3.61M
Total stockholder equity 0.61M 15.51M 37.26M 33.26M 11.70M
Deferred long term liab -